Viridian Therapeutics
VRDN
VRDN
51 hedge funds and large institutions have $37.4M invested in Viridian Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-5
Holders Change %
-8.93%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
19
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$430K |
| 2 |
Millennium Management
New York
|
+$196K |
| 3 |
6CM
683 Capital Management
New York
|
+$193K |
| 4 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
+$80.2K |
| 5 |
D.E. Shaw & Co
New York
|
+$74.1K |
Top Sellers
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.76M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.17M |
| 3 |
SG Americas Securities
New York
|
-$301K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$252K |
| 5 |
Morgan Stanley
New York
|
-$189K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $1K | -$56.2K | -730 | -98% |
|
|
SB
52
Samsara BioCapital
Palo Alto,
California
| – | -$2.76M | -60,606 | Closed |
|
|
OM
53
Opaleye Management
Boston,
Massachusetts
| – | -$1.17M | -25,667 | Closed |
|
|
54
SG Americas Securities
New York
| – | -$301K | -6,622 | Closed |
|
|
OAM
55
Oxford Asset Management
Oxford,
United Kingdom
| – | -$252K | -5,539 | Closed |
|
|
BWP
56
BSW Wealth Partners
Boulder,
Colorado
| – | -$67K | -1,482 | Closed |
|
57
Citadel Advisors
Miami,
Florida
| – | -$55K | -1,226 | Closed |
|
58
US Bancorp
Minneapolis,
Minnesota
| – | -$3K | -67 | Closed |
|
|
PHK
59
Point72 Hong Kong
Hong Kong
| – | -$1K | -15 | Closed |
|